In addition, ROC curve analysis showed that SERPINF1 expression could predict the 3-, 5-, and 8-year survival rates of glioma patients with high AUC, suggesting SERPINF1 has huge prospects as a novel prognostic predictor for glioma. Here, SERPINF1 is linked to central nervous system cancer.